Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes

Rheumatology International

Volumn 34, Issue 10, 2014, Pages 1401-1408

  Enevold, C ^a   Kjaer L ^a   Nielsen, C H ^a   Voss, A ^c   Jacobsen, R S ^a   Hermansen, M L F ^a   Redder, L ^c   Oturai, A B ^b   Jensen, P E ^b   Bendtzen, K ^a   Jacobsen, S ^a,b  

^a Rigshospitalet   (Denmark)

^b Rigshospitalet   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

DDX58; IFIH1; MDA5; RIG I; rs1990760; SLE; TLR3

Indexed keywords

DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; IFIH1 PROTEIN, HUMAN; RARRES3 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3;

ADOLESCENT; ADULT; AGED; ALLELE; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; DEAD-BOX RNA HELICASES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, RETINOIC ACID; TOLL-LIKE RECEPTOR 3; YOUNG ADULT;

EID: 84918788952     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3012-4     Document Type: Article

References (30)

1. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM et al (1998) A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 17:478–484
2. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM et al (1998) A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 17:468–477
3. Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NHH (2011) Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 63:3067–3077
4. Celhar T, Magalhães R, Fairhurst A-M (2012) TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol Res 53:58–77
5. Rönnblom L, Alm GV, Eloranta M-L (2011) The type I interferon system in the development of lupus. Semin Immunol 23:113–121
6. Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6:644–658
7. Midgley A, Thorbinson C, Beresford MW (2012) Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. Rheumatology (Oxford) 51:824–832
8. Martin DA, Elkon KB (2005) Autoantibodies make a U-turn: the toll hypothesis for autoantibody specificity. J Exp Med 202:1465–1469
9. Komatsuda A, Wakui H, Iwamoto K, Ozawa M, Togashi M, Masai R et al (2008) Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol 152:482–487
10. Wu O, Chen GP, Chen H, Li XP, Xu JH, Zhao SS et al (2009) The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population. Immunobiology 214:392–402
11. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732–738
12. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X et al (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41:1228–1233
13. Gono T, Kawaguchi Y, Sugiura T, Furuya T, Kawamoto M, Hanaoka M et al (2010) Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis. Mod Rheumatol 20:466–470
14. Cen H, Wang W, Leng R-X, Wang T-Y, Pan H-F, Fan Y-G et al (2013) Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity 6934:1–8
15. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S et al (2008) Association of systemic lupus erythematosus with C8orf13–BLK and ITGAM–ITGAX. N Engl J Med 358:900–909
16. Imaizumi T, Arikawa T, Sato T, Uesato R, Matsumiya T, Yoshida H et al (2008) Involvement of retinoic acid-inducible gene-I in inflammation of rheumatoid fibroblast-like synoviocytes. Clin Exp Immunol 153:240–244
17. Imaizumi T, Tanaka H, Tajima A, Tsuruga K, Oki E, Sashinami H et al (2010) Retinoic acid-inducible gene-I (RIG-I) is induced by IFN-γ in human mesangial cells in culture: possible involvement of RIG-I in the inflammation in lupus nephritis. Lupus 19:830–836
18. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
19. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
20. Enevold C, Oturai AB, Sørensen PS, Ryder LP, Koch-Henriksen N, Bendtzen K (2009) Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1. J Neuroimmunol Elsevier BV 212: 125–131
21. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM et al (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308–311
22. Wigginton JE, Cutler DJ, Abecasis GR (2005) A note on exact tests of Hardy–Weinberg equilibrium. Am J Hum Genet 76:887–893
23. Harley J, Alarcón-Riquelme M (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40:204–210
24. Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syvänen A-C, Rönnblom L et al (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 7:e1002341
25. Cen H, Leng R-X, Wang W, Zhou M, Feng C-C, Zhu Y et al (2013) Association study of IFIH1 rs1990760 polymorphism with systemic lupus erythematosus in a Chinese population. Inflammation 36:444–448
26. Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M et al (2011) Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients. J Immunol 187:1298–1303
27. Laska MJ, Troldborg A, Hansen B, Stengaard-Pedersen K, Junker P, Nexø BA et al (2014) Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females. Rheumatology (Oxford) 53(1):48–55
28. Hu J, Nistal-Villán E, Voho A, Ganee A, Kumar M, Ding Y et al (2010) A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells. J Immunol 185:424–432
29. Pothlichet J, Burtey A, Kubarenko AV, Caignard G, Solhonne B, Tangy F et al (2009) Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response. PLoS One 4:e7582
30. Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H et al (2000) Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9:664–671